The Food and Drug Administration has approved the first generic versions of Vyvanse, the prescription stimulant known for being "abuse-deterrent."…
On August 25, the New York Office of Public Safety held a briefing ahead of International Overdose Awareness Day. It…
On July 19, the National Institute on Drug Abuse awarded over $4.3 million to InterveXion Therapeutics, an Arkansas-based biopharmaceutical company…
For most of my 20s, running out of Adderall was the problem that put everything else on hold. If my…